Cargando…
Systemic Delivery of AAV-Fdxr Mitigates the Phenotypes of Mitochondrial Disorders in Fdxr Mutant Mice
Gene therapy now provides a novel approach for treating inherited monogenetic disorders, including nuclear gene mutations associated with mitochondrial diseases. In this study, we have utilized a mouse model carrying a p.Arg389Gln mutation of the mitochondrial Ferredoxin Reductase gene (Fdxr) and tr...
Autores principales: | Yang, Li, Slone, Jesse, Zou, Weiwei, Queme, Luis F., Jankowski, Michael P., Yin, Fei, Huang, Taosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488755/ https://www.ncbi.nlm.nih.gov/pubmed/32995353 http://dx.doi.org/10.1016/j.omtm.2020.05.021 |
Ejemplares similares
-
Integrated analysis of the molecular pathogenesis of FDXR-associated disease
por: Slone, Jesse D., et al.
Publicado: (2020) -
FDXR is a biomarker of radiation exposure in vivo
por: O’Brien, Gráinne, et al.
Publicado: (2018) -
Expanding the FDXR-Associated Disease Phenotype: Retinal Dystrophy Is a Recurrent Ocular Feature
por: Jurkute, Neringa, et al.
Publicado: (2021) -
PHA stimulation may be useful for FDXR gene expression-based biodosimetry
por: Vosoughi, Habibeh, et al.
Publicado: (2020) -
MON-635 FDXR Regulates Iron Metabolism and Glucose Metabolism in Liver
por: Sakuma, Ikki, et al.
Publicado: (2020)